Herzog, Roland W.Bungert, Jörg2023-07-102023-07-102021Herzog RW, Bungert J. Old versus new gene therapy for globin disorders. Mol Ther. 2021;29(6):1933-1934. doi:10.1016/j.ymthe.2021.04.031https://hdl.handle.net/1805/34252en-USPublisher PolicyGenetic therapyGlobinsbeta-thalassemiaOld versus new gene therapy for globin disordersArticle